The RpfB switch is a novel B12-sensing riboswitch regulating (non-replicating) persistence in Mycobacterium tuberculosis.

Terry Kipkorir,Peter Polgar,Alexandre D'Halluin,Brindha Gap-Gaupool,Vadim Makarov,Galina Mukamolova,Kristine Bourke Arnvig
DOI: https://doi.org/10.1101/2024.07.19.603033
2024-07-19
Abstract:Riboswitches are metabolite-sensing RNA elements that control a wide range of genes in bacteria. Most riboswitches identified to date are broadly conserved and control genes that are directly involved in the transport or biosynthesis of their cognate ligands. However, a minority of switches are restricted to a few species and in addition may bind less obvious ligands. One such switch controls the expression of the Mycobacterium tuberculosis rpfB operon, which is critical for resuscitation of dormant bacteria, ribosome maturation and reactivation of latent tuberculosis infection. The switch is restricted to pathogenic mycobacteria and until now, its ligand was unknown. However, in the current study, we identify the ligand as cobalamin or vitamin B12. Using in-line probing, we show that vitamin B12 binds directly to the riboswitch RNA, and we predict a structure based on the cleavage pattern. Moreover, we show that B12 suppresses the expression of an rpfB-lacZ reporter fusion and crucially, that B12 suppresses resuscitation of M. tuberculosis from a state of non-replicating persistence. These findings demonstrate a pivotal role of crosstalk between a host-derived metabolite and a pathogen riboswitch in controlling M. tuberculosis persistence with potential for improved interventions.
Biology
What problem does this paper attempt to address?